Abstract
Summary. Benefit‐cost analysis is a type of policy analysis still in a developing stage, particularly with respect to investments in people. Policy analysts, policy makers, and other users concur this type of analysis cannot be a sufficient basis for public policy decisions. For health programs, it is an approach that can supplement medical and epidemiologic bases for public investment decisions. It is a useful tool where an understanding of health problems is deficient in some areas. This paper discusses some examples of the use of benefit‐cost analysis in planning disease prevention programs and the explicit consideration to the quality of life benefits associated with reduced disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
